Literature DB >> 31197530

Clinicoradiologic characteristics of endolymphatic sac tumors.

Hongbo Le1, Huihong Zhang2, Weijing Tao3, Lan Lin4,5, Jie Li6, Lin Ma4, Guobin Hong7, Xin Lou8.   

Abstract

PURPOSE: Endolymphatic sac tumor (ELST) is a rare, slow-growing, and low-grade malignant tumor arising from the endolymphatic sac in the posterior petrous bone. The purpose of this study is to describe the clinical and radiologic features, and investigate the clinicoradiologic correlation of ELST.
METHODS: We retrospectively reviewed the clinical, computed tomography (CT), magnetic resonance imaging (MRI), and pathologic findings of 14 patients with 15 ELSTs.
RESULTS: Patients comprised of eight women and six men with a mean age of 42.3 years at the time of diagnosis and 35.2 years at the time of initial symptoms. The mean interval between initial symptoms and diagnosis was 84.7 months. The most frequent cochleovestibular symptom was hearing loss in 14 patients (100%); other cochleovestibular symptoms were tinnitus in eight patients (57.1%), vertigo in three patients (21.4%), and aural fullness in three patients (21.4%). Ten patients (71.4%) presented with facial paralyses and five patients (14.3%) presented lower cranial nerve deficits. CT findings revealed spiculated, stippled, or reticular high density within the tumors. The lesions involved mastoid cells, vertical facial nerve canal, semicircular canal, cochlea, tympanum, jugular foramen, internal auditory canal, or petrous apex. On the available MRI, all the eight lesions showed patchy and/or speckled hyperintensity on unenhanced T1WI. Five lesions showed flow voids on T2WI and T1WI. Three lesions had blood fluid levels within cysts.
CONCLUSION: CT and MRI findings of ELSTs are associated with clinical features. Imaging tests should be performed to identify ELSTs early and ensure greater potential for hearing preservation in patients with cochleovestibular symptoms.

Entities:  

Keywords:  Computed tomography; Endolymphatic sac tumor; Magnetic resonance imaging; Petrous bone

Mesh:

Year:  2019        PMID: 31197530     DOI: 10.1007/s00405-019-05511-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  37 in total

Review 1.  Evaluation and management of endolymphatic sac and duct tumors.

Authors:  Cliff A Megerian; Maroun T Semaan
Journal:  Otolaryngol Clin North Am       Date:  2007-06       Impact factor: 3.346

2.  Magnetic resonance and computed tomography imaging of a grade IV papillary endolymphatic sac tumour.

Authors:  Pieter Janse van Rensburg; Graeme van der Meer
Journal:  J Neurooncol       Date:  2008-05-07       Impact factor: 4.130

3.  Computed tomography and magnetic resonance imaging findings for primary middle-ear carcinoma.

Authors:  F Zhang; Y Sha
Journal:  J Laryngol Otol       Date:  2013-05-02       Impact factor: 1.469

4.  The endolymphatic sac: microsurgical topographic anatomy.

Authors:  M Ammirati; A Spallone; J Feghali; J Ma; M Cheatham; D Becker
Journal:  Neurosurgery       Date:  1995-02       Impact factor: 4.654

5.  Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry.

Authors:  Birke Bausch; Ulrich Wellner; Mathieu Peyre; Carsten C Boedeker; Frederik J Hes; Mariagiulia Anglani; Jose M de Campos; Hiroshi Kanno; Eamonn R Maher; Tobias Krauss; Gabriela Sansó; Marta Barontini; Claudio Letizia; Claudia Hader; Francesca Schiavi; Elisabetta Zanoletti; Carlos Suárez; Christian Offergeld; Angelica Malinoc; Stefan Zschiedrich; Sven Glasker; Serge Bobin; Olivier Sterkers; Patrice Tran Ba Huy; Sophie Giraud; Thera Links; Charis Eng; Giuseppe Opocher; Stephane Richard; Hartmut P H Neumann
Journal:  Head Neck       Date:  2015-07-14       Impact factor: 3.147

6.  Endolymphatic sac tumours: surgical management.

Authors:  Jörg Schipper; Wolfgang Maier; Steffen K Rosahl; Vera van Velthoven; Ansgar Berlis; Carsten Christof Boedeker; Roland Laszig; Christian Barna Teszler; Gerd Jürgen Ridder
Journal:  J Otolaryngol       Date:  2006-12

Review 7.  Temporal paragangliomas.

Authors:  Carlos Suárez; María A Sevilla; José L Llorente
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-03-02       Impact factor: 2.503

8.  Aggressive papillary middle-ear tumor. A clinicopathologic entity distinct from middle-ear adenoma.

Authors:  M J Gaffey; S E Mills; R E Fechner; S R Intemann; M R Wick
Journal:  Am J Surg Pathol       Date:  1988-10       Impact factor: 6.394

9.  Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease.

Authors:  John A Butman; H Jeffrey Kim; Martin Baggenstos; Joshua M Ammerman; James Dambrosia; Athos Patsalides; Nicholas J Patronas; Edward H Oldfield; Russell R Lonser
Journal:  JAMA       Date:  2007-07-04       Impact factor: 56.272

10.  Endolymphatic sac tumor in a 4-year-old boy.

Authors:  Michael E Kupferman; Douglas C Bigelow; David F Carpentieri; Larissa T Bilaniuk; Ken Kazahaya
Journal:  Otol Neurotol       Date:  2004-09       Impact factor: 2.311

View more
  2 in total

Review 1.  Symptoms and clinical features in patients affected by endolymphatic sac tumor: a systematic review and meta-analysis.

Authors:  Federico Maria Gioacchini; Shaniko Kaleci; Giuseppe Chiarella; Pasquale Viola; Davide Pisani; Alfonso Scarpa; Michele Tulli; Annalisa Pace; Giannicola Iannella; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-15       Impact factor: 3.236

2.  Endolymphatic Sac Tumor as a Ménière-Like Vertiginous Syndrome: A Case Report.

Authors:  Mario Jesus Villegas-González; Josefina Alejandra Morales-Del Angel; José Luis Treviño González; Daniel Aranda-Garcia; Germán Armando Soto-Galindo; Adriana Miroslava Pérez Peña
Journal:  J Int Adv Otol       Date:  2022-01       Impact factor: 1.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.